United States
info@cannaconsultinggroup.com
206-446-9291

Blog Details

Marijuana May Be Removed from Schedule 1 List

Originally listed as a Schedule 1 drug in 1970, the Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug. The call for analysis comes after a continued increase in state approved medical marijuana, with Colorado and Washington recently legalizing retail marijuana.

Schedule 1 drugs carry the most restrictions of the five DEA classifications and are considered substances with no medical benefit that are highly addictive. Factors the FDA considers in making a recommendation include a drug’s abuse potential, its pharmacological effect and risk to public health, according to Throckmorton’s written testimony.

The proposed change is a sign of the growing acceptance of marijuana as medicine and for recreational purposes in the US.

Article Link: http://www.bloomberg.com/news/2014-06-20/drug-regulators-study-easing-u-s-marijuana-restrictions.html

You’re ready for the next step and Canna Consulting Group is ready to help you take it. Let us know what you do and how we can help, and we will match you with one of our top consultants to take the lead on your project. We help our clients reach their objectives by offering direct services and insights that increase efficiencies and performances that boost returns on investments. We are prepared to help you reach your goals, now lets get started.

    Your Name (required)

    Your Email (required)

    Subject

    Areas of Interest

    Your Message